{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:53:10Z","timestamp":1794919990388,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Dev Biol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human Mesenchymal Stem Cells (hMSCs) represent a promising cell source for cell-based therapy in autoimmune diseases and other degenerative disorders due to their immunosuppressive, anti-inflammatory and regenerative potentials. Belonging to a glucocorticoid family, Dexamethasone (Dex) is a powerful anti-inflammatory compound that is widely used as therapy in autoimmune disease conditions or allogeneic transplantation. However, minimal immunomodulatory effect of hMSCs may limit their therapeutic uses. Moreover, the effect of glucocorticoids on the immunomodulatory molecules or other regenerative properties of tissue-specific hMSCs remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Herein, we evaluated the in vitro effect of Dex at various dose concentrations and time intervals, 1000\u00a0ng\/ml, 2000\u00a0ng\/ml, 3000\u00a0ng\/ml and 24\u00a0h, 48\u00a0h respectively, on the basic characteristics and immunomodulatory properties of Bone marrow derived MSC (BM-MSCs), Adipose tissue derived MSCs (AD-MSCs), Dental Pulp derived MSC (DP-MSCs) and Umbilical cord derived MSCs (UC-MSCs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The present study indicated that the concentration of Dex did not ramify the cellular morphology nor showed cytotoxicity as well as conserved the basic characteristics of tissue specific hMSCs including cell proliferation and surface marker profiling. However, quite interestingly it was observed that the stemness markers (Oct-4, Sox-2, Nanog and Klf-4) showed a significant upregulation in DP-MSCs and AD-MSCs followed by UC-MSCs and BM-MSCs. Additionally, immunomodulatory molecules, Prostaglandin E-2 (PGE-2), Indoleamine- 2,3-dioxygenase (IDO) and Human Leukocyte Antigen-G (HLA-G) were seen to be upregulated in a dose-dependent manner. Moreover, there was a differential response of tissue specific hMSCs after pre-conditioning with Dex during mixed lymphocyte reaction, wherein UC-MSCs and DP-MSCs showed enhanced immunosuppression as compared to AD-MSCs and BM-MSCs, thereby proving to be a better candidate for therapeutic applications in immune-related diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Dex preconditioning improved the hMSCs immunomodulatory property and may have reduced the challenge associated with minimal potency and strengthen their therapeutic efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                <jats:p>Preconditioning of tissue specific hMSCs with dexamethasone biomanufacturers the enhanced potential hMSCs with better stemness and immunomodulatory properties for future therapeutics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12861-021-00246-4","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T11:37:43Z","timestamp":1636025863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6518-3547","authenticated-orcid":false,"given":"Sonali","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsla","family":"Dadhwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"issue":"1","key":"246_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imr.12154","volume":"258","author":"EJ Fuchs","year":"2014","unstructured":"Fuchs EJ. Transplantation tolerance: from theory to clinic. Immunol Rev. 2014;258(1):64\u201379. https:\/\/doi.org\/10.1111\/imr.12154.","journal-title":"Immunol Rev"},{"issue":"6","key":"246_CR2","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1681\/ASN.V1061366","volume":"10","author":"JF Gummert","year":"1999","unstructured":"Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol. 1999;10(6):1366\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"246_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1191\/0961203305lu2109oa","volume":"2","author":"JC Wu","year":"1994","unstructured":"Wu JC. Mycophenolate mofetil: molecular mechanisms of action. Perspect Drug Discov Des. 1994;2:185\u2013204. https:\/\/doi.org\/10.1191\/0961203305lu2109oa.","journal-title":"Perspect. Drug Discov Des."},{"issue":"5","key":"246_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/bies.950180507","volume":"18","author":"ACB Cato","year":"1996","unstructured":"Cato ACB, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays. 1996;18(5):371\u20138. https:\/\/doi.org\/10.1002\/bies.950180507.","journal-title":"BioEssays"},{"issue":"11","key":"246_CR5","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/eji.200425418","volume":"34","author":"C Vitale","year":"2004","unstructured":"Vitale C, et al. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and\/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol. 2004;34(11):3028\u201338. https:\/\/doi.org\/10.1002\/eji.200425418.","journal-title":"Eur J Immunol"},{"issue":"9","key":"246_CR6","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1182\/blood-2006-07-037846","volume":"109","author":"L Chiossone","year":"2007","unstructured":"Chiossone L, et al. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood. 2007;109(9):3767\u201375. https:\/\/doi.org\/10.1182\/blood-2006-07-037846.","journal-title":"Blood"},{"issue":"5","key":"246_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12(5):383\u201396. https:\/\/doi.org\/10.1038\/nri3209.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"246_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/cr.2010.44","volume":"20","author":"Y Shi","year":"2010","unstructured":"Shi Y, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 2010;20(5):510\u20138. https:\/\/doi.org\/10.1038\/cr.2010.44.","journal-title":"Cell Res"},{"key":"246_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4285215","volume":"2016","author":"A Klimczak","year":"2016","unstructured":"Klimczak A, Kozlowska U. Mesenchymal stromal cells and tissue-specific progenitor cells: their role in tissue homeostasis. Stem Cells Int. 2016;2016:1\u201311. https:\/\/doi.org\/10.1155\/2016\/4285215.","journal-title":"Stem Cells Int."},{"issue":"2","key":"246_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","volume":"18","author":"M Najar","year":"2016","unstructured":"Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L. Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells. Cytotherapy. 2016;18(2):160\u201371. https:\/\/doi.org\/10.1016\/j.jcyt.2015.10.011.","journal-title":"Cytotherapy"},{"issue":"4","key":"246_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/CCLM.2000.040","volume":"38","author":"J Bienvenu","year":"2000","unstructured":"Bienvenu J, Monneret G, Fabien N, Revillard JP. The clinical usefulness of the measurement of cytokines. Clin Chem Lab Med. 2000;38(4):267\u201385. https:\/\/doi.org\/10.1515\/CCLM.2000.040.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"246_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13287-015-0178-y","volume":"6","author":"MW Lee","year":"2015","unstructured":"Lee MW, Ryu S, Kim DS, Sung KW, Koo HH, Yoo KH. Strategies to improve the immunosuppressive properties of human mesenchymal stem cells. Stem Cell Res Ther. 2015;6(1):179. https:\/\/doi.org\/10.1186\/s13287-015-0178-y.","journal-title":"Stem Cell Res Ther"},{"key":"246_CR13","unstructured":"A. Bernards et al., A class I antigen, HLA-G, expressed in human trophoblasts. Science 1989; 3860, 0\u20133."},{"issue":"12","key":"246_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/molehr\/7.12.1167","volume":"7","author":"CL Aldrich","year":"2001","unstructured":"Aldrich CL. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod. 2001;7(12):1167\u201372. https:\/\/doi.org\/10.1093\/molehr\/7.12.1167.","journal-title":"Mol Hum Reprod"},{"issue":"9","key":"246_CR15","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1073\/pnas.89.9.3947","volume":"89","author":"A Ishitani","year":"1992","unstructured":"Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA. 1992;89(9):3947\u201351. https:\/\/doi.org\/10.1073\/pnas.89.9.3947.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"246_CR16","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood. 2009;113(26):6576\u201383. https:\/\/doi.org\/10.1182\/blood-2009-02-203943.","journal-title":"Blood"},{"key":"246_CR17","doi-asserted-by":"publisher","unstructured":"Kuschner, \u201c\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access. Physiol Behav. 2017; 176(3), 139\u2013148. https:\/\/doi.org\/10.1016\/j.physbeh.2017.03.040.","DOI":"10.1016\/j.physbeh.2017.03.040"},{"key":"246_CR18","doi-asserted-by":"crossref","unstructured":"Amodio G, Gregori S, Distinctive immunological functions of HLA-G. 2011.","DOI":"10.5772\/35248"},{"issue":"3","key":"246_CR19","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/jcmm.13492","volume":"22","author":"C Hu","year":"2018","unstructured":"Hu C, Li L. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J Cell Mol Med. 2018;22(3):1428\u201342. https:\/\/doi.org\/10.1111\/jcmm.13492.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"246_CR20","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s11999-014-3925-y","volume":"473","author":"CC Wyles","year":"2015","unstructured":"Wyles CC, Houdek MT, Wyles SP, Wagner ER, Behfar A, Sierra RJ. Differential Cytotoxicity of Corticosteroids on Human Mesenchymal Stem Cells. Clin Orthop Relat Res. 2015;473(3):1155\u201364. https:\/\/doi.org\/10.1007\/s11999-014-3925-y.","journal-title":"Clin Orthop Relat Res"},{"key":"246_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.22203\/eCM.v022a23","volume":"22","author":"N Shintani","year":"2011","unstructured":"Shintani N, Hunziker EB. Differential effects of dexamethasone on the chondrogenesis of mesenchymal stromal cells: influence of microenvironment, tissue origin and growth factor. Eur Cells Mater. 2011;22:302\u201320. https:\/\/doi.org\/10.22203\/eCM.v022a23.","journal-title":"Eur Cells Mater"},{"issue":"S1","key":"246_CR22","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1038\/cr.2008.206","volume":"18","author":"Y Xiao","year":"2008","unstructured":"Xiao Y, Peperzak V, van Rijn L, Borst J, de Bruijn J. Dexamethasone treatment during the expansion phase sustains stemness of mesenchymal stem cells from human bone marrow. Cell Res. 2008;18(S1):S116\u2013S116. https:\/\/doi.org\/10.1038\/cr.2008.206.","journal-title":"Cell Res"},{"key":"246_CR23","doi-asserted-by":"crossref","unstructured":"Nandy SB, Mohanty S, Singh M, Behari M, Airan B, Fibroblast growth factor-2 alone as an efficient inducer for differentiation of human bone marrow mesenchymal stem cells into dopaminergic neurons. pp. 1\u201310; 2014.","DOI":"10.1186\/s12929-014-0083-1"},{"issue":"6","key":"246_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.9790\/0853-1706143240","volume":"17","author":"S Rawat","year":"2018","unstructured":"Rawat S, Srivastava P, Mohanty S, Prabha P, Gupta S, Kanga U. A comparative study on immunomodulatory potential of tissue specific hMSCs: role of HLA-G mesenchymal stem cells in immunomodulation: a potential candidate for therapeutic intervention? View project evaluation of therapeutic potential of tissue specific M. IOSR J Dent Med Sci e-ISSN. 2018;17(6):32\u201340. https:\/\/doi.org\/10.9790\/0853-1706143240.","journal-title":"IOSR J Dent Med Sci e-ISSN"},{"issue":"08","key":"246_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.9790\/0853-150807102111","volume":"15","author":"A Kakkar","year":"2016","unstructured":"Kakkar A, Sharma P, Sankar MM, Kharbanda O, Mohanty S. Effect of hypoxia on stemness and differentiation of dental pulp derived stem cells. IOSR J Dent Med Sci. 2016;15(08):102\u201311. https:\/\/doi.org\/10.9790\/0853-150807102111.","journal-title":"IOSR J Dent Med Sci"},{"issue":"4","key":"246_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s12026-016-8798-6","volume":"64","author":"W Chen","year":"2016","unstructured":"Chen W, et al. Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunol Res. 2016;64(4):831\u201340. https:\/\/doi.org\/10.1007\/s12026-016-8798-6.","journal-title":"Immunol Res"},{"issue":"4","key":"246_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"246_CR28","doi-asserted-by":"publisher","unstructured":"Akhter A, Faridi RM, Das V, Pandey A, Naik S, Agrawal S, In vitro up-regulation of HLA-G using dexamethasone and hydrocortisone in first-trimester trophoblast cells of women experiencing recurrent miscarriage. 2012; 8:126\u2013135. https:\/\/doi.org\/10.1111\/j.1399-0039.2012.01884.","DOI":"10.1111\/j.1399-0039.2012.01884"},{"key":"246_CR29","doi-asserted-by":"crossref","unstructured":"Akhter A, Das V, Pandey A, Agrawal S, Effect of glucocorticoids on transcriptional status of HLA-G in human trophoblast cells from full term placenta. 2010; 10(4):223\u2013229.","DOI":"10.1080\/09723757.2010.11886109"},{"issue":"9624","key":"246_CR30","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371(9624):1579\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(08)60690-X.","journal-title":"Lancet"},{"issue":"3","key":"246_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","volume":"33","author":"Y Shi","year":"2012","unstructured":"Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 2012;33(3):136\u201343. https:\/\/doi.org\/10.1016\/j.it.2011.11.004.","journal-title":"Trends Immunol"},{"key":"246_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2013.537","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, et al. The interaction between mesenchymal stem cells and steroids during inflammation. Cell Death Dis. 2014;5:1\u201312. https:\/\/doi.org\/10.1038\/cddis.2013.537.","journal-title":"Cell Death Dis"},{"issue":"2","key":"246_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jor.23270","volume":"35","author":"TH Lin","year":"2017","unstructured":"Lin TH, et al. Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF-\u03baB activity. J Orthop Res. 2017;35(2):281\u20138. https:\/\/doi.org\/10.1002\/jor.23270.","journal-title":"J Orthop Res"},{"issue":"11","key":"246_CR34","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.exphem.2008.06.008","volume":"36","author":"WK Chan","year":"2008","unstructured":"Chan WK, Lau AS-Y, Li JC-B, Law HK-W, Lau YL, Chan GC-F. \u201cMHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-\u03b3 challenge. Exp Hematol. 2008;36(11):1545\u201355. https:\/\/doi.org\/10.1016\/j.exphem.2008.06.008.","journal-title":"Exp Hematol"},{"issue":"2","key":"246_CR35","doi-asserted-by":"publisher","first-page":"e9016","DOI":"10.1371\/journal.pone.0009016","volume":"5","author":"SJ Prasanna","year":"2010","unstructured":"Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, IFN\u03b3 and TNF\u03b1, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLOS ONE. 2010;5(2):e9016. https:\/\/doi.org\/10.1371\/journal.pone.0009016.","journal-title":"PLOS ONE"},{"key":"246_CR36","doi-asserted-by":"publisher","unstructured":"Schneider N et al., Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior. pp 1\u201320; 2015. https:\/\/doi.org\/10.1371\/journal.pone.0120538.","DOI":"10.1371\/journal.pone.0120538"},{"issue":"4","key":"246_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/14653249.2011.652735","volume":"14","author":"H Wang","year":"2012","unstructured":"Wang H, Pang B, Li Y, Zhu D, Pang T, Liu Y. Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy. 2012;14(4):423\u201330. https:\/\/doi.org\/10.3109\/14653249.2011.652735.","journal-title":"Cytotherapy"},{"issue":"4","key":"246_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.11637\/kjpa.2007.20.4.311","volume":"20","author":"IH Song","year":"2007","unstructured":"Song IH, Kim SY. Effects of dexamethasone on proliferation of mesenchymal stem cells in long term culture. Korean J Phys Anthropol. 2007;20(4):311. https:\/\/doi.org\/10.11637\/kjpa.2007.20.4.311.","journal-title":"Korean J Phys Anthropol"},{"issue":"1\u20132","key":"246_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jsbmb.2009.05.007","volume":"116","author":"D Hong","year":"2009","unstructured":"Hong D, et al. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol. 2009;116(1\u20132):86\u201392. https:\/\/doi.org\/10.1016\/j.jsbmb.2009.05.007.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"246_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8178643","volume":"2017","author":"X Lu","year":"2017","unstructured":"Lu X, et al. PGE2 Promotes the migration of mesenchymal stem cells through the activation of FAK and ERK1\/2 Pathway. Stem Cells Int. 2017;2017:1\u201311. https:\/\/doi.org\/10.1155\/2017\/8178643.","journal-title":"Stem Cells Int"},{"issue":"2","key":"246_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cdd.2013.158","volume":"21","author":"S Ma","year":"2014","unstructured":"Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ. 2014;21(2):216\u201325. https:\/\/doi.org\/10.1038\/cdd.2013.158.","journal-title":"Cell Death Differ"},{"issue":"8","key":"246_CR42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/cr.2008.80","volume":"18","author":"H Sheng","year":"2008","unstructured":"Sheng H, et al. A critical role of IFN\u03b3 in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7\u2013H1. Cell Res. 2008;18(8):846\u201357. https:\/\/doi.org\/10.1038\/cr.2008.80.","journal-title":"Cell Res"},{"key":"246_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrep.2016.07.019","volume":"8","author":"L Meesuk","year":"2016","unstructured":"Meesuk L, Tantrawatpan C, Kheolamai P, Manochantr S. The immunosuppressive capacity of human mesenchymal stromal cells derived from amnion and bone marrow. Biochem Biophys Reports. 2016;8:34\u201340. https:\/\/doi.org\/10.1016\/j.bbrep.2016.07.019.","journal-title":"Biochem Biophys Reports"},{"key":"246_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep04645","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Dastidar RG, Ong JF, Levy O, Karp JM. Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci Rep. 2014. https:\/\/doi.org\/10.1038\/srep04645.","journal-title":"Sci Rep"},{"issue":"3","key":"246_CR45","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/S0041-1345(01)01990-X","volume":"33","author":"P Moreau","year":"2001","unstructured":"Moreau P, et al. Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant Proc. 2001;33(3):2277\u201380. https:\/\/doi.org\/10.1016\/S0041-1345(01)01990-X.","journal-title":"Transplant Proc"},{"key":"246_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trim.2016.04.008","volume":"37","author":"CM Michelo","year":"2016","unstructured":"Michelo CM, et al. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation. Transpl Immunol. 2016;37:1\u20139. https:\/\/doi.org\/10.1016\/j.trim.2016.04.008.","journal-title":"Transpl Immunol"}],"container-title":["BMC Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12861-021-00246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12861-021-00246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12861-021-00246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T11:38:53Z","timestamp":1636025933000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcdevbiol.biomedcentral.com\/articles\/10.1186\/s12861-021-00246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s12861-021-00246-4","relation":{},"ISSN":["1471-213X"],"issn-type":[{"value":"1471-213X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Mesenchymal Stromal Cells and Peripheral Blood used in this study were isolated from healthy donors with written consent after obtaining ethical clearance from Institutional Committee for Stem Cell research (ICSCR), and Institutional Ethical Clearance (IEC), AIIMS, New Delhi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}